Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Kerioui

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Statistical Methods in Medical Research|August 19, 2024
New clinical trial design borrowing information across patient subgroups based on fusion-penalized regression modelsMarion Kerioui, Alexia Iasonos, Mithat Gönen, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 1, 2020
Longitudinal analysis of organ-specific tumor lesion sizes in metastatic colorectal cancer patients receiving first line standard chemotherapy in combination with anti-angiogenic treatmentFrancois Mercier, Marion Kerioui, Solène Desmée, et al.
British Journal of Clinical Pharmacology|January 7, 2022
Modelling the association between biomarkers and clinical outcome: An introduction to nonlinear joint modelsMarion Kerioui, Julie Bertrand, René Bruno, et al.
Clinical Pharmacology and Therapeutics|April 16, 2019
Association Between Tumor Size Kinetics and Survival in Patients With Urothelial Carcinoma Treated With Atezolizumab: Implication for Patient Follow-UpCoralie Tardivon, Solène Desmée, Marion Kerioui, et al.
Statistics in Medicine|October 8, 2020
Bayesian inference using Hamiltonian Monte-Carlo algorithm for nonlinear joint modeling in the context of cancer immunotherapyMarion Kerioui, Francois Mercier, Julie Bertrand, et al.
JCO Precision Oncology|February 27, 2023
Assessing the Increased Variability in Individual Lesion Kinetics During Immunotherapy: Does It Exist, and Does It Matter?Marion Kerioui, Julie Bertrand, Solène Desmée, et al.
Elife|September 27, 2021
Quantifying the relationship between SARS-CoV-2 viral load and infectiousnessAurélien Marc, Marion Kerioui, François Blanquart, et al.
Biometrics|July 27, 2023
Nonlinear multilevel joint model for individual lesion kinetics and survival to characterize intra-individual heterogeneity in patients with advanced cancerMarion Kerioui, Maxime Beaulieu, Solène Desmée, et al.
Plos Computational Biology|August 9, 2023
Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primatesAurélien Marc, Romain Marlin, Flora Donati, et al.
Diseases of the Colon and Rectum|December 21, 2023
Anal Adenocarcinoma Treated in the Era of Total Neoadjuvant Therapy and Nonoperative ManagementYael Feferman, Roni Y Rosen, Selim Gebran, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Statistical Methods in Medical Research|August 19, 2024
New clinical trial design borrowing information across patient subgroups based on fusion-penalized regression modelsMarion Kerioui, Alexia Iasonos, Mithat Gönen, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 1, 2020
Longitudinal analysis of organ-specific tumor lesion sizes in metastatic colorectal cancer patients receiving first line standard chemotherapy in combination with anti-angiogenic treatmentFrancois Mercier, Marion Kerioui, Solène Desmée, et al.
British Journal of Clinical Pharmacology|January 7, 2022
Modelling the association between biomarkers and clinical outcome: An introduction to nonlinear joint modelsMarion Kerioui, Julie Bertrand, René Bruno, et al.
Clinical Pharmacology and Therapeutics|April 16, 2019
Association Between Tumor Size Kinetics and Survival in Patients With Urothelial Carcinoma Treated With Atezolizumab: Implication for Patient Follow-UpCoralie Tardivon, Solène Desmée, Marion Kerioui, et al.
Statistics in Medicine|October 8, 2020
Bayesian inference using Hamiltonian Monte-Carlo algorithm for nonlinear joint modeling in the context of cancer immunotherapyMarion Kerioui, Francois Mercier, Julie Bertrand, et al.
JCO Precision Oncology|February 27, 2023
Assessing the Increased Variability in Individual Lesion Kinetics During Immunotherapy: Does It Exist, and Does It Matter?Marion Kerioui, Julie Bertrand, Solène Desmée, et al.
Elife|September 27, 2021
Quantifying the relationship between SARS-CoV-2 viral load and infectiousnessAurélien Marc, Marion Kerioui, François Blanquart, et al.
Biometrics|July 27, 2023
Nonlinear multilevel joint model for individual lesion kinetics and survival to characterize intra-individual heterogeneity in patients with advanced cancerMarion Kerioui, Maxime Beaulieu, Solène Desmée, et al.
Plos Computational Biology|August 9, 2023
Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primatesAurélien Marc, Romain Marlin, Flora Donati, et al.
Diseases of the Colon and Rectum|December 21, 2023
Anal Adenocarcinoma Treated in the Era of Total Neoadjuvant Therapy and Nonoperative ManagementYael Feferman, Roni Y Rosen, Selim Gebran, et al.
Pageof 2